会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • High-pressure drive system
    • 高压驱动系统
    • US06296605B1
    • 2001-10-02
    • US09344209
    • 1999-06-24
    • Paul C. MichelmanR. Mitchell Baldwin, IIHoward R. Levin
    • Paul C. MichelmanR. Mitchell Baldwin, IIHoward R. Levin
    • A61M110
    • A61M1/1068A61M1/106A61M1/1065A61M1/12
    • A high pressure inflation system for driving an inflatable heart assistance device. The system includes a fluid source for supplying a fluid at a relatively high pressure and a compression tank plumbed in selective communication with the pneumatic source. The compression tank is operative to store a predetermined volume of the pressurized fluid at approximately the high pressure created by the fluid source. A transfer valve is disposed downstream of the compression tank and is coupled to the heart assistance device. The compression tank and transfer valve are maintained in close proximal relation to the heart assistance device with the transfer valve being responsive to predetermined signals to expose the heart assistance device to the compression tank pressure and expand the device to compress and assist the heart.
    • 用于驱动充气式心脏辅助装置的高压膨胀系统。 该系统包括用于供应相对较高压力的流体的流体源和与气源选择性连通的压缩罐。 压缩箱可操作以将预定体积的加压流体存储在大致由流体源产生的高压下。 转移阀设置在压缩罐的下游并且耦合到心脏辅助装置。 压缩罐和转换阀保持与心脏辅助装置的近近关系,转移阀响应于预定信号,以使心脏辅助装置暴露于压缩罐压力,并使装置膨胀以压缩和辅助心脏。
    • 10. 发明授权
    • Methods for treating a condition or disease associated with cardio-renal function
    • 治疗与心肾功能相关的病症或疾病的方法
    • US08175711B2
    • 2012-05-08
    • US11368553
    • 2006-03-06
    • Denise DemaraisHanson Gifford, IIIMark DeemDouglas SuttonHoward R. LevinMark Gelfand
    • Denise DemaraisHanson Gifford, IIIMark DeemDouglas SuttonHoward R. LevinMark Gelfand
    • A61N1/00A61F7/00A61K9/22
    • A61N1/05A61N1/0551A61N1/327A61N1/40
    • Methods and apparatus are provided for treating congestive heart failure, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.
    • 提供了用于经由脉冲电场,经由刺激电场,经由局部药物递送,经由高频超声波,经由热技术等治疗充血性心力衰竭的方法和装置。这种神经调节可以实现不可逆的电穿孔或电融合, 凋亡的坏死和/或诱导,基因表达的改变,动作电位衰减或阻断,细胞因子上调的变化和靶神经纤维中的其他条件。 在一些实施方案中,神经调节被应用于有助于肾功能的神经纤维。 在一些实施方案中,这种神经调节以双向方式进行。 与单侧执行的肾神经调节相比,双侧肾神经调节可以在一些患者中提供增强的治疗效果,即与在支配单个肾脏的神经组织上进行的肾神经调节相比。